Black Lung Benefits Improvement Act of 2022

H.R. 6102 - Black Lung Benefits Improvement Act of 2021 OWCP Black Lung Self-Insurance Rule

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021 OWCP Black Lung Self-Insurance Rule

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021 OWCP Black Lung Self-Insurance Rule

Client expense: $350,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021 OWCP Black Lung Self-Insurance Rule

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

H.R. 6102, Black Lung Benefits Improvement Act of 2021, All Titles S. 4511, Black Lung Benefits Improvement Act of 2022, All Titles H.J. Res. 100, Providing a Resolution to Avert a Rail Strike Shutdown

Client expense: $530,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements. Outreach/meetings on PREVENT Pandemics Act (S.3799) and ARPA-H Authorization (S.3819, H.R.5585, H.R.6000)

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Work in support of H.R.6102, The Black Lung Benefits Improvement Act of 2021, H.R.3114, The Longshore and Harbor Workers COVID-19 Compensation Act, a bill which establishes a presumption of compensability for Longshore covered workers who contract COVID-19 of 2021 and H.R.6087, The Improving Access to Workers Compensation for Federal Employees Act, which authorizes the use and availability of nurse practitioners to provide care to injured federal workers under the FECA program. Work in support of increased funding for Administration of the Department of Labor's Office of Workers Compensation Programs.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to improving the black lung benefits system, such as the Relief for Survivors of Miners Act of 2021, S. 757, and the Black Lung Benefits Improvement Act, H.R. 6102/S.4511. Issues related to the promulgation of a silica rule at the Mine Safety & Health Administration.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Mine Safety & Health Administration (MSHA), SENATE

H.R. 6102, Black Lung Benefits Improvement Act of 2021, All Titles S. 4511, Black Lung Benefits Improvement Act of 2022, All Titles S.J. Res. 61, A joint resolution to provide for the resolution of issues in a railway labor-management dispute, and for other purposes H.J. Res. 95, to provide for the resolution of issues in a railway labor-management dispute, and for other purposes

Client expense: $630,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements. Outreach/meetings on PREVENT Pandemics Act (S.3799) and ARPA-H Authorization (S.3819, H.R.5585, H.R.6000)

Client expense: $520,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Issues related to improving the black lung benefits system, such as the Relief for Survivors of Miners Act of 2021, S. 757, and the Black Lung Benefits Improvement Act, H.R. 6102/S.4511. Issues related to the promulgation of a silica rule at the Mine Safety & Health Administration.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Mine Safety & Health Administration (MSHA), SENATE

Work in support of H.R.6102, The Black Lung Benefits Improvement Act of 2021, H.R.3114, The Longshore and Harbor Workers COVID-19 Compensation Act, a bill which establishes a presumption of compensability for Longshore covered workers who contract COVID-19 of 2021 and H.R.6087, The Improving Access to Workers Compensation for Federal Employees Act, which authorizes the use and availability of nurse practitioners to provide care to injured federal workers under the FECA program. Work in support of increased funding for Administration of the Department of Labor's Office of Workers Compensation Programs.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements. Outreach/meetings on PREVENT Pandemics Act (S.3799) and ARPA-H Authorization (S.3819, H.R.5585, H.R.6000)

Client expense: $520,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to improving the black lung benefits system, such as the Relief for Survivors of Miners Act of 2021, S. 757, and the Black Lung Benefits Improvement Act, H.R. 6102/S.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Work in support of H.R.6102, The Black Lung Benefits Improvement Act of 2021, H.R.3114, The Longshore and Harbor Workers COVID-19 Compensation Act, a bill which establishes a presumption of compensability for Longshore covered workers who contract COVID-19 of 2021 and H.R.6087, The Improving Access to Workers Compensation for Federal Employees Act, which authorizes the use and availability of nurse practitioners to provide care to injured federal workers under the FECA program. Work in support of increased funding for Administration of the Department of Labor's Office of Workers Compensation Programs.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6102 - Black Lung Benefits Improvement Act of 2021

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements. Outreach/meetings on PREVENT Pandemics Act (S.3799) and ARPA-H Authorization (S.3819, H.R.5585, H.R.6000)

Client expense: $420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

H.R. 6102, Black Lung Benefits Improvement Act of 2021, All Titles H.R. 6462, Black Lung Benefits Disability Trust Fund Solvency Act of 2022, All Titles S. 2810, Back Lung Benefits Disability Trust Fund Solvency Act of 2021, All Titles

Client expense: $513,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Issues related to improving the black lung benefits system, such as the Relief for Survivors of Miners Act of 2021, S. 757, and the Black Lung Benefits Improvement Act, H.R. 6102.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements.

Client expense: $410,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, U.S. Coast Guard (USCG)

American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements.

Client expense: $430,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, U.S. Coast Guard (USCG)

- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees

Client expense: $450,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements.

Client expense: $430,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA)

Diagnostic test reimbursement and policies COVID-19 preparedness products and services American Rescue Plan implementation Proposals related to preserving medical supply chain Proposals related to COVID-19 medical device regulation Proposals related to newborn screening H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements.

Client expense: $420,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA)

H.R. 6102, The Families First Coronavirus Response Act, P.L. 116-227, provisions related to essential worker designation, transportation, and farm stimulus programs. H.R. 748, Coronavirus Aid, Relief and Economic Security Action, provisions related to farm programs.

Client expense: $181,628 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees

Client expense: $450,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 791 / S. 236, the Tracking COVID-19 Variants Act, provisions relating to funding COVID-19 surveillance and transmission studies using next generation sequencing; H.R. 1319, Pub. L. 117-2, the American Rescue Plan Act of 2021, provisions relating to funding for genomic sequencing for SARS-CoV-2 variants and diagnostic testing for COVID-19; H.R. 1946, the Medicare Multi-Cancer Detection Screening Coverage Act, provisions relating to Medicare coverage of multi-cancer screening tests; H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements; H.R. 1848, the LIFT America Act, provisions relating to funding of public health infrastructure and public health reporting; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; Federal policy relating to coverage of genetic counselor services in a draft of the Rare Cancer Awareness, Research and Treatment Act; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to drug development, including potential legislation known as Cures 2.0; and Federal policy relating to CDC funding for harmonizing lab results in the Fiscal Year 2022 Labor-HHS appropriations bill.